Your browser doesn't support javascript.
loading
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.
Ogata, Ryosuke; Soda, Hiroshi; Senju, Hiroaki; Fujioka, Masaki; Shimada, Midori; Yamashita, Koki; Irifune, Satoshi; Tagawa, Ryuta; Dotsu, Yosuke; Iwasaki, Keisuke; Taniguchi, Hirokazu; Takemoto, Shinnosuke; Fukuda, Yuichi; Mukae, Hiroshi.
Afiliación
  • Ogata R; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Soda H; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Senju H; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Fujioka M; Department of Respiratory Medicine, Senju Hospital, Nagasaki, Japan.
  • Shimada M; Department of Plastic and Reconstructive Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
  • Yamashita K; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Irifune S; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Tagawa R; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Dotsu Y; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Iwasaki K; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Taniguchi H; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Takemoto S; Department of Pathology, Sasebo City General Hospital, Nagasaki, Japan.
  • Fukuda Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Thorac Cancer ; 13(19): 2812-2816, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35974707
ABSTRACT
Extraskeletal myxoid chondrosarcoma (EMCS) is an undifferentiated mesenchymal malignancy; however, its immune microenvironment remains to be elucidated. The case of a 34-year-old woman who developed EMCS metastasizing to the pleura is presented here. The pleural EMCS showed hypervascularity, absent PD-L1 expression, and a lack of tumor mutational burden and pathogenic variants. Immunohistological examination of the pleural lesions showed predominant M2 macrophages and sparse CD8+ T cells. EMCS and the tumor stroma were positive for transforming growth factor-ß1 (TGF-ß1) and vascular endothelial growth factor (VEGF). In contrast, a small number of the stromal vessels were positive for hypoxia inducible factor-1α (HIF-1α). TGF-ß1 and VEGF in the tumor stroma and low antigenicity of the tumor cells may help explain how EMCS induced the immunosuppressive microenvironment. These findings may encourage investigators to explore novel combined immunotherapy for EMCS, such as TGF-ß1 and VEGF inhibitors, and specific therapy for enhancing tumor antigens.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Condrosarcoma / Factor de Crecimiento Transformador beta1 Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Condrosarcoma / Factor de Crecimiento Transformador beta1 Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article